Literature DB >> 11851649

Pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase efavirenz.

Rosario Calvo, John C Lukas, Monica Rodriguez, M Angeles Carlos, Elena Suarez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11851649      PMCID： PMC1874300          DOI： 10.1046/j.0306-5251.2001.01539.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  12 in total

1.  Population pharmacokinetics of methadone in opiate users: characterization of time-dependent changes.

Authors:  A Rostami-Hodjegan; K Wolff; A W Hay; D Raistrick; R Calvert; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

2.  Pharmacokinetics and safety of escalating single and repeat oral doses of GW420867X, a novel non-nucleoside reverse transcriptase inhibitor.

Authors:  K H Moore; L M Cass; N Dallow; T C Hardman; A Jones; M Boyce; W T Prince
Journal:  Eur J Clin Pharmacol       Date:  2001 Jan-Feb       Impact factor: 2.953

3.  The roles of P-glycoprotein and intracellular metabolism in the intestinal absorption of methadone: in vitro studies using the rat everted intestinal sac.

Authors:  R Bouër; L Barthe; C Philibert; C Tournaire; J Woodley; G Houin
Journal:  Fundam Clin Pharmacol       Date:  1999       Impact factor: 2.748

4.  Methadone maintenance treatment: is it possible to adapt the daily doses to the metabolic activity of the patient?

Authors:  C Charlier; M C Dessalles; G Plomteux
Journal:  Ther Drug Monit       Date:  2001-02       Impact factor: 3.681

5.  Alpha 1-acid glycoprotein (AAG) and serum protein binding of methadone in heroin addicts with abstinence syndrome.

Authors:  M J Garrido; C Aguirre; I F Trocóniz; M Marot; M Valle; M K Zamacona; R Calvo
Journal:  Int J Clin Pharmacol Ther       Date:  2000-01       Impact factor: 1.366

6.  Elevated alpha-1-acid glycoprotein reduces the volume of distribution and systemic clearance of saquinavir.

Authors:  J W Holladay; M J Dewey; B B Michniak; H Wiltshire; D L Halberg; P Weigl; Z Liang; K Halifax; W E Lindup; D J Back
Journal:  Drug Metab Dispos       Date:  2001-03       Impact factor: 3.922

7.  The pharmacokinetics of methadone in healthy subjects and opiate users.

Authors:  K Wolff; A Rostami-Hodjegan; S Shires; A W Hay; M Feely; R Calvert; D Raistrick; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  1997-10       Impact factor: 4.335

8.  Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients.

Authors:  D J Foster; A A Somogyi; K R Dyer; J M White; F Bochner
Journal:  Br J Clin Pharmacol       Date:  2000-11       Impact factor: 4.335

9.  Alpha 1-acid glycoprotein levels in AIDS patients before and after short-term treatment with zidovudine (ZDV)

Authors:  S Oie; M A Jacobson; D I Abrams
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-05

10.  Pharmacokinetics of methadone in methadone maintenance treatment: characterization of therapeutic failures.

Authors:  M I Nilsson; L Grönbladh; E Widerlöv; E Anggård
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953
View more
  1 in total

1.  Efficacy, adherence and tolerability of once daily tenofovir DF-containing antiretroviral therapy in former injecting drug users with HIV-1 receiving opiate treatment: results of a 48-week open-label study.

Authors:  S Esser; A Haberl; F Mulcahy; J Gölz; A Lazzarin; E Teofilo; J Vera; A Körber; S Staszewski
Journal:  Eur J Med Res       Date:  2011-10-10       Impact factor: 2.175
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.